Skip to main content
OpenTrials
Completed

NCT Number: NCT00056511

Comparing Effects of 3 Sources of Garlic on Cholesterol Levels

The purpose of this study is to determine whether fresh garlic can positively affect cholesterol in adults with moderately high cholesterol levels. This study will also determine whether the same effects can be found for two main types of garlic supplements: a dried powdered garlic (designed to yield the same effect as fresh garlic) and an aged garlic extract preparation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Stanford Center for Research in Disease Prevention

Palo Alto, California, 94304-1583, United States

About this study

Garlic supplements are the most consumed herbal products in the United States. The most common health claim made for garlic supplements is cholesterol lowering activity. This claim has not been supported by recent clinical trials and meta-analyses. However, data suggest that it is not necessarily the garlic that has been ineffective, but rather the particular garlic preparations being used. To date, the predominant type of garlic preparation used in these clinical trials has been dried garlic powders. A few clinical trials have reported beneficial lipid effects using an aged garlic extract, and only a small number of inconclusive uncontrolled trials have used fresh garlic. A rigorous trial directly comparing different types of garlic preparations for their effects on serum lipids is needed.

Adults with moderately elevated low density lipoprotein cholesterol (LDL-C) will be randomized to one of four groups for 6 months: fresh garlic, dried powdered garlic tablets, aged garlic extract tablets, or placebo control. The fresh garlic will be provided to patients with "study sandwiches"; all other groups will receive the same study sandwiches without the garlic. All patients will take daily study tablets, but the tablet assignment will be double-blind. Patients will pick up study sandwiches twice a week and study tablets once every 2 weeks for 28 weeks. Blood samples will be taken once a month, with additional blood draws at the start and end of the study.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • LDL-C 130-190 mg/dL (fasting single sample)
  • BMI (body mass index) 19-30 kg/m2 (42-66 lb/m2)
  • Weight stable for last 2 months
  • Not actively on a weight loss plan
  • Ethnicity representative of local population
  • No plans to move from the area over the next 9 months

Exclusion criteria

  • Pregnant, lactating, within 6 months postpartum, or planning to become pregnant in the next year
  • Diabetes (type I or II) or history of gestational diabetes
  • Heart disease
  • Active neoplasms
  • Renal or liver disease
  • Hyperthyroidism or hypothyroidism
  • Lipid lowering medications (known to affect lipid metabolism, platelet function, or antioxidant status)
  • Blood pressure medications
  • Excessive alcohol intake (self reported, more than 3 drinks/day)
  • Currently under psychiatric care or severely clinically depressed

Treatment and study plan

Fresh garlic or garlic supplements

Drug

Primary outcomes

  1. LDL-cholesterol; measured at baseline, once a month, and post-intervention

Secondary outcomes

  1. HDL-cholesterol; measured at baseline, once a month, and post-intervention

  2. Triacylglycerols; measured at baseline, once a month, and post-intervention

  3. Blood pressure; measured at baseline, once a month, and post-intervention

  4. Platelet aggregation; measured at baseline, once a month, and post-intervention

Sponsors and collaborators

Lead sponsor

National Center for Complementary and Integrative Health (NCCIH)

Nih

Collaborators

  • Office of Dietary Supplements (ODS)

Registry information

Official study title

Comparing Effects of 3 Sources of Garlic on Serum Lipids

Important dates

Study start
2002
Study completion
2005
First posted
Mar 18, 2003
Registry last updated
Aug 18, 2006

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.